Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Risk factors and clinical outcomes of endoscopic dilation in benign esophageal strictures: a long-term follow-up study.

Vermeulen BD, de Zwart M, Sijben J, Soons E, van der Weerd L, Arese D, von den Hoff DW, Craviotto V, Tan ACITL, Groenen MJM, Bogte A, Repici A, Spaander MCW, Siersema PD.

Gastrointest Endosc. 2020 Jan 6. pii: S0016-5107(20)30001-8. doi: 10.1016/j.gie.2019.12.040. [Epub ahead of print]

PMID:
31917167
2.

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.

Kooyker AI, Toes-Zoutendijk E, Opstal-van Winden AWJ, Spaander MCW, Buskermolen M, van Vuuren HJ, Kuipers EJ, van Kemenade FJ, Ramakers C, Thomeer MGJ, Dekker E, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I.

Int J Cancer. 2019 Dec 19. doi: 10.1002/ijc.32839. [Epub ahead of print]

PMID:
31853977
3.

Intralesional steroid injections to prevent refractory strictures in patients with oesophageal atresia: study protocol for an international, multicentre randomised controlled trial (STEPS-EA trial).

Ten Kate CA, Vlot J, IJsselstijn H, Allegaert K, Spaander MCW, Poley MJ, van Rosmalen J, van den Akker ELT, Wijnen RMH.

BMJ Open. 2019 Dec 16;9(12):e033030. doi: 10.1136/bmjopen-2019-033030.

4.

Endoscopic ultrasound and fine-needle aspiration for the detection of residual nodal disease after neoadjuvant chemoradiotherapy for esophageal cancer.

van der Bogt RD, van der Wilk BJ, Poley JW, Krishnadath KK, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, Bruno MJ, Biermann K, van Lanschot JJB, Spaander MCW.

Endoscopy. 2019 Dec 9. doi: 10.1055/a-1065-1759. [Epub ahead of print]

PMID:
31816658
5.

Cost-effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome Cases.

Peterse EFP, Naber SK, Daly C, Pollett A, Paszat LF, Spaander MCW, Aronson M, Gryfe R, Rabeneck L, Lansdorp-Vogelaar I, Baxter NN.

Clin Gastroenterol Hepatol. 2019 Oct 17. pii: S1542-3565(19)31165-6. doi: 10.1016/j.cgh.2019.10.021. [Epub ahead of print]

PMID:
31629885
6.

Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.

van der Wilk BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, Nieuwenhuijzen GAP, Sosef MN, van Berge Henegouwen MI, Lagarde SM, Spaander MCW, Valkema R, Biermann K, Wijnhoven BPL, van der Gaast A, van Lanschot JJB, Doukas M, Nikkessen S, Luyer M, Schoon EJ, Roef MJ, van Lijnschoten I, Oostenbrug LE, Riedl RG, Gisbertz SS, Krishnadath KK, Bennink RJ, Meijer SL; Collaborators:.

Ann Surg. 2019 Oct 4. doi: 10.1097/SLA.0000000000003636. [Epub ahead of print]

PMID:
31592898
7.

A Quarter of Participants With Advanced Neoplasia Have Discordant Results From 2-Sample Fecal Immunochemical Tests for Colorectal Cancer Screening.

Wieten E, de Klerk CM, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW.

Clin Gastroenterol Hepatol. 2019 Sep 26. pii: S1542-3565(19)31030-4. doi: 10.1016/j.cgh.2019.09.024. [Epub ahead of print]

PMID:
31563557
8.

Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study.

Nieuwenburg SAV, Waddingham WW, Graham D, Rodriguez-Justo M, Biermann K, Kuipers EJ, Banks M, Jansen M, Spaander MCW.

BMJ Open. 2019 Sep 18;9(9):e032013. doi: 10.1136/bmjopen-2019-032013.

9.

Adherence to recommendations of Barrett's esophagus surveillance guidelines: a systematic review and meta-analysis.

Roumans CAM, van der Bogt RD, Steyerberg EW, Rizopoulos D, Lansdorp-Vogelaar I, Sharma P, Spaander MCW, Bruno MJ.

Endoscopy. 2020 Jan;52(1):17-28. doi: 10.1055/a-0995-0134. Epub 2019 Sep 17.

PMID:
31529444
10.

Evaluation of Gastroesophageal Reflux in Children Born With Esophageal Atresia Using pH and Impedance Monitoring.

Vergouwe FWT, van Wijk MP, Spaander MCW, Bruno MJ, Wijnen RMH, Schnater JM, IJsselstijn H.

J Pediatr Gastroenterol Nutr. 2019 Nov;69(5):515-522. doi: 10.1097/MPG.0000000000002468.

PMID:
31490855
11.

Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes.

Goverde A, Eikenboom EL, Viskil EL, Bruno MJ, Doukas M, Dinjens WNM, Dubbink HJ, van den Ouweland AMW, Hofstra RMW, Wagner A, Spaander MCW.

Clin Gastroenterol Hepatol. 2019 Aug 27. pii: S1542-3565(19)30918-8. doi: 10.1016/j.cgh.2019.08.043. [Epub ahead of print]

PMID:
31470178
12.

Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.

Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I; Dutch National Colorectal Cancer Screening Working Group.

Clin Gastroenterol Hepatol. 2019 Aug 20. pii: S1542-3565(19)30896-1. doi: 10.1016/j.cgh.2019.08.021. [Epub ahead of print]

13.

Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.

Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt PMM, Kuipers EJ, Dekker E, Spaander MCW.

Clin Gastroenterol Hepatol. 2019 Aug 13. pii: S1542-3565(19)30890-0. doi: 10.1016/j.cgh.2019.08.015. [Epub ahead of print]

PMID:
31419575
14.

Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort Study.

Bleijenberg AGC, IJspeert JEG, Carballal S, Pellise M, Jung G, van Herwaarden YJ, Bisseling TM, Nagtegaal ID, van Leerdam ME, Spaander MCW, van Lelyveld N, Bessa X, Rodríguez-Alcalde D, Bastiaansen BAJ, de Klaver W, Bemelman WA, Bujanda L, Koornstra JJ, Rivero L, Rodríguez-Moranta F, Balaguer F, Dekker E.

Am J Gastroenterol. 2019 Sep;114(9):1512-1519. doi: 10.14309/ajg.0000000000000339.

PMID:
31403493
15.

Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.

Suzuki L, Ten Kate FJC, Gotink AW, Stoop H, Doukas M, Nieboer D, Spaander MCW, van Lanschot JJB, van Wijnhoven BPL, Koch AD, Bruno MJ, Looijenga LHJ, Biermann K.

PLoS One. 2019 Jul 8;14(7):e0219494. doi: 10.1371/journal.pone.0219494. eCollection 2019.

16.

Through-the-scope placement of a fully covered metal stent for palliation of malignant dysphagia: a prospective cohort study (with video).

Vermeulen BD, Reijm AN, van der Bogt RD, van Hooft JE, Spaander MCW, Siersema PD.

Gastrointest Endosc. 2019 Dec;90(6):972-979. doi: 10.1016/j.gie.2019.06.030. Epub 2019 Jun 29.

PMID:
31265819
17.

Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients.

Faria AVS, Andrade SS, Reijm AN, Spaander MCW, de Maat MPM, Peppelenbosch MP, Ferreira-Halder CV, Fuhler GM.

J Clin Med. 2019 Jun 28;8(7). pii: E936. doi: 10.3390/jcm8070936.

18.

Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.

Schreuders EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, van Roon AHC, van Vuuren AJ, Lansdorp-Vogelaar I, Spijker WWJ, Izelaar K, Bruno MJ, Kuipers EJ, Spaander MCW.

Lancet Gastroenterol Hepatol. 2019 Aug;4(8):622-631. doi: 10.1016/S2468-1253(19)30176-1. Epub 2019 Jun 10.

PMID:
31196734
19.

Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.

Eyck BM, Onstenk BD, Noordman BJ, Nieboer D, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB.

Ann Surg. 2020 Feb;271(2):245-256. doi: 10.1097/SLA.0000000000003397.

PMID:
31188203
20.

Endoscopic grading of gastric intestinal metaplasia: can we do it without pathologists?

Spaander MCW.

Endoscopy. 2019 Jun;51(6):509-510. doi: 10.1055/a-0831-2450. Epub 2019 May 28. No abstract available.

PMID:
31137073
21.

Reply.

Oey RC, Spaander MCW, van Buuren HR, de Man RA.

Hepatology. 2019 Nov;70(5):1875-1876. doi: 10.1002/hep.30781. No abstract available.

22.

HOXA9 mediates and marks premalignant compartment size expansion in colonic adenomas.

Janmaat VT, Liu H, da Silva RA, Wisse PHA, Spaander MCW, Ten Hagen TLM, Smits R, Bruno MJ, Fuhler GM, Peppelenbosch MP.

Carcinogenesis. 2019 Dec 31;40(12):1514-1524. doi: 10.1093/carcin/bgz038.

PMID:
31099823
23.

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.

Vuik FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, Dinis-Ribeiro M, Bento MJ, Zadnik V, Pellisé M, Esteban L, Kaminski MF, Suchanek S, Ngo O, Májek O, Leja M, Kuipers EJ, Spaander MC.

Gut. 2019 Oct;68(10):1820-1826. doi: 10.1136/gutjnl-2018-317592. Epub 2019 May 16.

24.

Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett's-associated adenocarcinoma?

Nesteruk K, Spaander MCW, Leeuwenburgh I, Peppelenbosch MP, Fuhler GM.

Biochim Biophys Acta Rev Cancer. 2019 Dec;1872(2). pii: S0304-419X(19)30028-9. doi: 10.1016/j.bbcan.2019.04.007. Epub 2019 May 4. Review.

25.

Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.

Bleijenberg AG, IJspeert JE, van Herwaarden YJ, Carballal S, Pellisé M, Jung G, Bisseling TM, Nagetaal ID, van Leerdam ME, van Lelyveld N, Bessa X, Rodríguez-Moranta F, Bastiaansen B, de Klaver W, Rivero L, Spaander MC, Koornstra JJ, Bujanda L, Balaguer F, Dekker E.

Gut. 2020 Jan;69(1):112-121. doi: 10.1136/gutjnl-2018-318134. Epub 2019 Apr 13.

26.

Effects of Oral Anticoagulant and Aspirin Use on Ability of Fecal Immunochemical Tests to Detect Advanced Neoplasia.

Spaander MCW, Kuipers EJ.

Gastroenterology. 2019 May;156(6):1553-1555. doi: 10.1053/j.gastro.2019.03.031. Epub 2019 Mar 26. No abstract available.

PMID:
30926342
27.

Accuracy of 18F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.

Valkema MJ, Noordman BJ, Wijnhoven BPL, Spaander MCW, Biermann K, Lagarde SM, Bennink RJ, Schreurs WMJ, Roef MJ, Hobbelink MGG, Janssen MJR, Graven LH, van Lanschot JJB, Valkema R.

J Nucl Med. 2019 Nov;60(11):1553-1559. doi: 10.2967/jnumed.118.224196. Epub 2019 Mar 15.

PMID:
30877177
28.

Participation and Ease of Use in Colorectal Cancer Screening: A Comparison of 2 Fecal Immunochemical Tests.

de Klerk CM, Wieten E, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MCW, Dekker E.

Am J Gastroenterol. 2019 Mar;114(3):511-518. doi: 10.14309/ajg.0000000000000148.

PMID:
30789417
29.

The Yield and Safety of Screening Colonoscopy in Patients Evaluated for Liver Transplantation.

Oey RC, van Tilburg L, Erler NS, Metselaar HJ, Spaander MCW, van Buuren HR, de Man RA.

Hepatology. 2019 Jun;69(6):2598-2607. doi: 10.1002/hep.30562. Epub 2019 Apr 6.

30.

Treatment of refractory post-esophagectomy anastomotic esophageal strictures using temporary fully covered esophageal metal stenting compared to repeated bougie dilation: results of a randomized controlled trial.

Kappelle WF, van Hooft JE, Spaander MCW, Vleggaar FP, Bruno MJ, Maluf-Filho F, Bogte A, van Halsema E, Siersema PD.

Endosc Int Open. 2019 Feb;7(2):E178-E185. doi: 10.1055/a-0777-1856. Epub 2019 Jan 18.

31.

Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program.

Toes-Zoutendijk E, Bonfrer JMG, Ramakers C, Thelen M, Spaander MCW, Dekker E, van der Meulen MP, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, van Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I.

Clin Chem. 2019 Mar;65(3):419-426. doi: 10.1373/clinchem.2018.294041. Epub 2019 Jan 16.

PMID:
30651228
32.

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.

Rigter LS, Spaander MCW, Aleman BMP, Bisseling TM, Moons LM, Cats A, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM, Snaebjornsson P, Kuipers EJ, Bruno MJ, Dekker E, Meijer GA, de Boer JP, van Leeuwen FE, van Leerdam ME.

Cancer. 2019 Mar 15;125(6):990-999. doi: 10.1002/cncr.31903. Epub 2018 Dec 18.

33.

Palliation of dysphagia.

van der Bogt RD, Vermeulen BD, Reijm AN, Siersema PD, Spaander MCW.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:97-103. doi: 10.1016/j.bpg.2018.11.010. Epub 2018 Nov 22. Review.

PMID:
30551864
34.

Neoadjuvant chemoradiotherapy for resectable oesophageal cancer.

Eyck BM, van der Wilk BJ, Lagarde SM, Wijnhoven BPL, Valkema R, Spaander MCW, Nuyttens JJME, van der Gaast A, van Lanschot JJB.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:37-44. doi: 10.1016/j.bpg.2018.11.007. Epub 2018 Nov 22. Review.

PMID:
30551855
35.

Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.

de Klerk CM, Wieten E, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MC, Dekker E.

Lancet Gastroenterol Hepatol. 2019 Feb;4(2):111-118. doi: 10.1016/S2468-1253(18)30319-4. Epub 2018 Nov 27.

PMID:
30497962
36.

Endoscopic ultrasound measurements for detection of residual disease after neoadjuvant chemoradiotherapy for esophageal cancer.

van der Bogt RD, Noordman BJ, Krishnadath KK, Roumans CAM, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, van Lanschot JJB, Spaander MCW.

Endoscopy. 2019 Apr;51(4):326-332. doi: 10.1055/a-0795-3220. Epub 2018 Nov 29.

PMID:
30497088
37.

When to stop colonoscopy surveillance in the elderly?

Spaander MCW, Vuik F, Nieuwenburg SAV.

Neth J Med. 2018 Oct;76(8):350. No abstract available.

38.

Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program.

Bronzwaer MES, Depla ACTM, van Lelyveld N, Spanier BWM, Oosterhout YH, van Leerdam ME, Spaander MCW, Dekker E; Dutch Colonoscopy Quality Assurance working group.

Gastrointest Endosc. 2019 Jan;89(1):1-13. doi: 10.1016/j.gie.2018.09.011. Epub 2018 Sep 18. Review.

PMID:
30240879
39.

Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer.

van der Wilk BJ, Eyck BM, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB.

Dig Surg. 2019;36(6):462-469. doi: 10.1159/000493435. Epub 2018 Sep 18. Review.

40.

Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.

Goverde A, Wagner A, Bruno MJ, Hofstra RMW, Doukas M, van der Weiden MM, Dubbink HJ, Dinjens WNM, Spaander MCW.

Gastroenterology. 2018 Nov;155(5):1410-1415. doi: 10.1053/j.gastro.2018.07.029. Epub 2018 Jul 29.

PMID:
30063919
41.

Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.

Wieten E, de Klerk CM, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW.

Gastroenterology. 2018 Nov;155(5):1392-1399.e5. doi: 10.1053/j.gastro.2018.07.021. Epub 2018 Jul 25.

PMID:
30055170
42.

Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma.

Hamade N, Vennelaganti S, Parasa S, Vennalaganti P, Gaddam S, Spaander MCW, van Olphen SH, Thota PN, Kennedy KF, Bruno MJ, Vargo JJ, Mathur S, Cash BD, Sampliner R, Gupta N, Falk GW, Bansal A, Young PE, Lieberman DA, Sharma P.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):864-868. doi: 10.1016/j.cgh.2018.07.008. Epub 2018 Aug 8.

PMID:
30012433
43.

Risk factors for refractory anastomotic strictures after oesophageal atresia repair: a multicentre study.

Vergouwe FWT, Vlot J, IJsselstijn H, Spaander MCW, van Rosmalen J, Oomen MWN, Hulscher JBF, Dirix M, Bruno MJ, Schurink M, Wijnen RMH; DCEA Study Group.

Arch Dis Child. 2019 Feb;104(2):152-157. doi: 10.1136/archdischild-2017-314710. Epub 2018 Jul 14.

PMID:
30007949
44.

A novel device for intracolonoscopy cleansing of inadequately prepared colonoscopy patients: a feasibility study.

van Keulen KE, Neumann H, Schattenberg JM, van Esch AAJ, Kievit W, Spaander MCW, Siersema PD.

Endoscopy. 2019 Jan;51(1):85-92. doi: 10.1055/a-0632-1927. Epub 2018 Jul 11.

PMID:
29996152
45.

Self-expandable metal stent placement for malignant esophageal strictures - changes in clinical outcomes over time.

Reijm AN, Didden P, Schelling SJC, Siersema PD, Bruno MJ, Spaander MCW.

Endoscopy. 2019 Jan;51(1):18-29. doi: 10.1055/a-0644-2495. Epub 2018 Jul 10.

PMID:
29991071
46.

Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.

Wieten E, Schreuders EH, Grobbee EJ, Nieboer D, Bramer WM, Lansdorp-Vogelaar I, Bruno MJ, Kuipers EJ, Spaander MCW.

Gut. 2019 May;68(5):873-881. doi: 10.1136/gutjnl-2017-315340. Epub 2018 Jun 22.

PMID:
29934436
47.

Natural History of Barrett's Esophagus.

Kuipers EJ, Spaander MC.

Dig Dis Sci. 2018 Aug;63(8):1997-2004. doi: 10.1007/s10620-018-5161-x. Review.

48.

Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study).

Didden P, Reijm AN, Erler NS, Wolters LMM, Tang TJ, Ter Borg PCJ, Leeuwenburgh I, Bruno MJ, Spaander MCW.

Endoscopy. 2018 Oct;50(10):961-971. doi: 10.1055/a-0620-8135. Epub 2018 Jun 12.

PMID:
29895072
49.

Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions.

den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Hartog GD, Bruno MJ, Peppelenbosch MP, Lesterhuis W, Doukas M, Kuipers EJ, Spaander MCW.

Gut. 2019 Apr;68(4):585-593. doi: 10.1136/gutjnl-2017-314498. Epub 2018 Jun 6.

PMID:
29875257
50.

Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.

Nieuwenburg SAV, Vuik FER, Kruip MJHA, Kuipers EJ, Spaander MCW.

Gut. 2019 May;68(5):866-872. doi: 10.1136/gutjnl-2018-316344. Epub 2018 Jun 5.

PMID:
29871970

Supplemental Content

Loading ...
Support Center